Synonyms: Compound 1 [WO2022109595] | example F91 [WO2013033070] | THB-335 | THB335
Compound class:
Synthetic organic
Comment: The structure for labuxtinib was obtained from proposed INN list 129 (August 2023) where it is described as a tyrosine kinase inhibitor and antineoplastic agent. Patent information suggests that it is a KIT inhibitor [1-2]. It is most likely that labuxtinib is the INN for Third Harmonic Bio's candidate KIT inhibitor THB335. Development of the initial clinical lead THB001 was discontinued in late 2022 when hepatotoxicity was observed in a phase 1b study. THB335 is a follow-up molecule with structural modifications to address the toxicity risk, and is still in active development. As of January 2025 no structures have been formally declared for either of these inhibitors.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-[5-[5-[(1R,2S)-2-fluorocyclopropyl]-1,2,4-oxadiazol-3-yl]-2-methylphenyl]imidazo[1,2-a]pyridine-3-carboxamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
12711 | labuxtinib |
Synonyms ![]() |
Compound 1 [WO2022109595] | example F91 [WO2013033070] | THB-335 | THB335 |
Database Links ![]() |
|
BindingDB Ligand | 193999 |
CAS Registry No. | 1426449-01-5 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL3962292 |
GtoPdb PubChem SID | 485205991 |
PubChem CID | 71280305 |
Search Google for chemical match using the InChIKey | RHNJOZCVGSBEAG-KBPBESRZSA-N |
Search Google for chemicals with the same backbone | RHNJOZCVGSBEAG |
Search PubMed clinical trials | labuxtinib |
Search PubMed titles | labuxtinib |
Search PubMed titles/abstracts | labuxtinib |
UniChem Compound Search for chemical match using the InChIKey | RHNJOZCVGSBEAG-KBPBESRZSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | RHNJOZCVGSBEAG-KBPBESRZSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Labuxtinib (links to external site)
Cat. No. HY-156619 |